文献速递心脏核医学

胺碘酮降低大鼠心脏铷-82 PET/CT摄取

Amiodarone attenuates cardiac Rubidium-82 in consecutive PET/CT scans in a rodent model.
PubMed 文献 · J Nucl Cardiol · 2021-10-05

结果显示仅胺碘酮组心脏与肌肉SUV比值较基线显著降低(5.8 vs 5.1,P=.008),其他药物均无显著差异。

要点

  • 胺碘酮组心脏与肌肉SUV比值从基线5.8降至随访5.1(P=.008)。
  • 对照组及其他冠心病治疗药物组SUV比值无显著变化。
  • 胺碘酮可能影响绝对心肌血流的动力学参数评估。

核心结论

  • 在健康大鼠中,常用冠心病治疗药物不影响铷-82心脏摄取,但胺碘酮显著降低铷-82摄取。

主要发现

  • 对照组心脏与肌肉SUV比值从基线至随访无差异(5.8 vs 7.0,P=.3)。
  • 胺碘酮组SUV比值从基线至随访显著降低(5.8 vs 5.1,P=.008)。
  • 其余所有研究的药物组SUV比值从基线至随访均无差异。

临床怎么用

  • 胺碘酮可能不改变临床心肌灌注缺损的大小评估,但可能影响接受胺碘酮治疗患者的绝对心肌血流动力学参数评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risk stratification and diagnosis using Rubidium-82 (82Rb) positron emission tomography (PET) is a routine clinical approach in coronary artery disease (CAD). Various drugs are used to treat CAD; however, whether any of them change the uptake of 82Rb in the heart has not been investigated. The aim of this study is to determine whether drugs used in treatment of CAD affect the uptake of 82Rb in the heart in healthy rats. METHODS: Seventy-seven Sprague-Dawley rats were included in the cross-sectional study. All rats underwent baseline 82Rb PET/CT and divided into eleven groups treated with different drugs. One group was control group (no treatment), eight groups were treated with monotherapy (amiodarone, acetylsalicylic acid (ASA), clopidogrel, ticagrelor, atorvastatin, enalapril, amlodipine, metoprolol succinate), and two groups were treated with polypharmacy (ASA, ticagrelor, atorvastatin, amlodipine or ASA, clopidogrel, atorvastatin, amlodipine). Once a day, they were administered pharmacological therapy through oral gavage, and on day seven, follow-up scanned with 82Rb PET/CT. RESULTS: In the control group without pharmacological treatment, no difference in the standard uptake value (SUV) ratio between heart and muscle from baseline to follow-up (5.8 vs 7.0, P = .3) was found. The group treated with amiodarone had a significantly reduced SUV ratio from baseline to follow-up (5.8 vs 5.1, P = .008). All other drugs investigated had no difference in SUV ratio from baseline to follow-up. CONCLUSION: In this study, we showed that drugs normally used to treat CAD do not affect the uptake of 82Rb. However, amiodarone result in a significantly lowered 82Rb uptake, compared to control. This information about amiodarone would probably not change the size assessment of a myocardial perfusion defect in a clinical setting. However, it could change the kinetic parameters when assessing absolute myocardial blood flow in patients treated with amiodarone.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Bentsen S, Bang LE, Hasbak P, et al. Amiodarone attenuates cardiac Rubidium-82 in consecutive PET/CT scans in a rodent model. J Nucl Cardiol. 2021. PMID: 34611850. doi:10.1007/s12350-021-02785-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。